Company Profile

Company Overview

Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterials to treat multi-drug resistant (MDR), gram-negative infections.

Our Mission: We are driven by science and are passionately committed to the discovery, development, and commercialization of innovative treatments that will address the growing unmet need for treatments for multi-drug resistant gram-negative bacterial infections.

Our Values: We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative and one that encourages diversity of thought to promote great innovation. We are anchored in our work community by our key values.